- Home
- PRTS vs ONCY Comparison
PRTS vs ONCY Comparison
Compare PRTS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ONCY
- Stock Information
- Founded
- PRTS 1995
- ONCY 1998
- Country
- PRTS United States
- ONCY Canada
- Employees
- PRTS N/A
- ONCY N/A
- Industry
- PRTS Auto & Home Supply Stores
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PRTS Consumer Discretionary
- ONCY Health Care
- Exchange
- PRTS Nasdaq
- ONCY Nasdaq
- Market Cap
- PRTS 52.5M
- ONCY 56.2M
- IPO Year
- PRTS 2007
- ONCY 1999
- Fundamental
- Price
- PRTS $0.94
- ONCY $0.73
- Analyst Decision
- PRTS Buy
- ONCY Strong Buy
- Analyst Count
- PRTS 3
- ONCY 2
- Target Price
- PRTS $1.60
- ONCY $4.00
- AVG Volume (30 Days)
- PRTS 389.0K
- ONCY 563.2K
- Earning Date
- PRTS 03-06-2025
- ONCY 03-06-2025
- Dividend Yield
- PRTS N/A
- ONCY N/A
- EPS Growth
- PRTS N/A
- ONCY N/A
- EPS
- PRTS N/A
- ONCY N/A
- Revenue
- PRTS $611,705,000.00
- ONCY N/A
- Revenue This Year
- PRTS N/A
- ONCY N/A
- Revenue Next Year
- PRTS $1.58
- ONCY N/A
- P/E Ratio
- PRTS N/A
- ONCY N/A
- Revenue Growth
- PRTS N/A
- ONCY N/A
- 52 Week Low
- PRTS $0.68
- ONCY $0.67
- 52 Week High
- PRTS $2.68
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- PRTS 35.16
- ONCY 40.10
- Support Level
- PRTS $1.04
- ONCY $0.71
- Resistance Level
- PRTS $1.06
- ONCY $0.79
- Average True Range (ATR)
- PRTS 0.07
- ONCY 0.04
- MACD
- PRTS -0.02
- ONCY 0.00
- Stochastic Oscillator
- PRTS 1.45
- ONCY 32.71
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.